Suppr超能文献

2013 年至 2015 年期间马来西亚吉隆坡肠道病毒 D68 感染的血清流行病学研究。

Seroepidemiology of enterovirus D68 infection in Kuala Lumpur, Malaysia between 2013 and 2015.

机构信息

Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

出版信息

J Med Virol. 2022 Jun;94(6):2607-2612. doi: 10.1002/jmv.27381. Epub 2021 Oct 13.

Abstract

Enterovirus D68 (EV-D68) is an emerging respiratory pathogen since the 2014 outbreak in the United States. A low level of virus circulation has been reported in Kuala Lumpur, Malaysia, in the past. However, the extent of the infection in Malaysia is not known. In the present study, we determine the seroepidemiology of EV-D68 in Kuala Lumpur, Malaysia, before and after the United States outbreak in August 2014. A luciferase-based seroneutralization test was developed using a clone-derived prototype Fermon strain carrying a nanoluciferase marker. We screened the neutralization capacity of 450 serum samples from children and adults (1-89 years old) collected between 2013 and 2015. EV-D68 seropositivity increased with age, with children aged 1-3 showing significantly lower seroprevalence compared to adults. Multivariate analysis showed that older age groups 13-49 years (odds ratio [OR] = 4.78; 95% confidence interval [CI] = 2.69-8.49; p < 0.0001) and ≥50 years (OR = 3.83; 95% CI = 2.19-6.68; p < 0.0001) were more likely to be EV-D68 seropositive than children <13 years. Sampling post-September 2014 compared to pre-Sept 2014 also predicted seropositivity (OR = 1.66; 95% CI = 1.04-2.65). The presence of neutralizing antibodies against EV-D68 in the study population suggests that EV-D68 was circulating before 2014. A higher seropositivity post-September 2014 suggests that Malaysia also experienced an upsurge in EV-D68 infections after the United States outbreaks in August 2014. A low seropositivity rate observed in children, especially those aged 1-3 years old, suggests that they are at risk and should be prioritized for future vaccination.

摘要

肠道病毒 D68(EV-D68)是一种新兴的呼吸道病原体,自 2014 年美国疫情爆发以来一直在传播。过去,马来西亚吉隆坡曾有过低水平的病毒循环。然而,马来西亚的感染程度尚不清楚。在本研究中,我们在 2014 年 8 月美国疫情爆发前后,确定了马来西亚吉隆坡的 EV-D68 血清流行病学情况。使用携带纳米荧光素酶标记的克隆衍生原型 Fermon 株,建立了基于荧光素酶的血清中和试验。我们筛选了 2013 年至 2015 年间收集的 450 名儿童和成人(1-89 岁)血清样本的中和能力。EV-D68 血清阳性率随年龄增长而增加,1-3 岁儿童的血清阳性率明显低于成年人。多变量分析显示,年龄较大的 13-49 岁(比值比 [OR] = 4.78;95%置信区间 [CI] = 2.69-8.49;p < 0.0001)和≥50 岁(OR = 3.83;95% CI = 2.19-6.68;p < 0.0001)人群比<13 岁儿童更易 EV-D68 血清阳性。与 2014 年 9 月前相比,2014 年 9 月后采样也预测血清阳性(OR = 1.66;95% CI = 1.04-2.65)。研究人群中存在针对 EV-D68 的中和抗体表明,EV-D68 在 2014 年之前就已经在传播。2014 年 9 月后血清阳性率较高表明,马来西亚在 2014 年 8 月美国疫情爆发后,EV-D68 感染也出现了激增。在儿童中观察到的低血清阳性率,尤其是 1-3 岁儿童,表明他们处于风险之中,应优先考虑未来的疫苗接种。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验